Aflac Inc. (AFL, Financial) experienced a notable stock price drop of 5.02%. The stock is currently priced at $101.91 per share with a trading volume of 2.15 million shares and a turnover rate of 0.39%. The stock's volatility is marked by a 4.10% amplitude.
Recent financial reports reveal that Aflac Inc. achieved a revenue of $18.927 billion and a net profit of $5.443 billion, with earnings per share (EPS) of $9.68. The price-to-earnings (P/E) ratio stands at 10.59. Among 18 institutions providing ratings, 17% recommend buying, 61% suggest holding, and 22% advise selling the stock.
Within the insurance sector, where Aflac Inc. operates, the overall growth is 0.68%. Notable gainers in the sector include Markel Group Inc., Horace Mann, and Abacus Life Inc. C/Wts 30/06/2028 (To Pur Com). Meanwhile, Lemonade, Inc., Root, Inc., and Reliance Global Group, Inc. show significant trading activity with turnover rates of 2.06%, 1.59%, and 1.59%, respectively. Abacus Life Inc. C/Wts 30/06/2028 (To Pur Com), Twfg, Inc., and Oxbridge Re Holdings Limited exhibit high volatility with amplitudes of 12.80%, 10.76%, and 9.53%.
Aflac Inc. provides supplemental health and life insurance in the U.S. and Japan, including cancer, accident, dental, vision, disability, and long-term care insurance. The company markets its products through independent distributors, primarily at consumer workplaces, and also reaches customers digitally outside the workplace. Aflac Japan and Aflac U.S. are its two main business segments.
